Cyclacel Pharmaceuticals CYCCP

Annual report 2025
added 03-30-2026

Cyclacel Pharmaceuticals DPO Ratio 2011-2026 | CYCCP

Annual DPO Ratio Cyclacel Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.79 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.79 K	1.79 K	1.79 K

DPO Ratio of other stocks in the Biotechnology industry

	Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
	I-Mab IMAB	2.24 K	-	-	$ 866 M	China
	Akebia Therapeutics AKBA	168	$ 1.4	-0.71 %	$ 360 M	USA
	Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
	Aytu BioScience AYTU	186	$ 2.55	-0.78 %	$ 16 M	USA
	Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
	AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
	Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
	Amphastar Pharmaceuticals AMPH	31.7	$ 20.37	-2.4 %	$ 952 M	USA
	Aquestive Therapeutics AQST	395	$ 4.08	-2.16 %	$ 436 M	USA
	Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
	Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
	Arcutis Biotherapeutics ARQT	133	$ 24.21	-1.47 %	$ 3.08 B	USA
	BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
	Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
	AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
	Celldex Therapeutics CLDX	4.06 K	$ 32.24	-4.1 %	$ 2.14 B	USA
	AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
	Avid Bioservices CDMO	62.3	-	-	$ 789 M	USA